Fundz
An acquisition means integration work is about to be scoped. Fundz scores the company against what you sell, and says why it matched.See it live →

Kincell Bio and Cellipont Bioservices Merge

PRIVATESep 17, 2026about 3 hours ago

Acquiring Company

Kincell Bio

Acquired Company

Cellipont Bioservices

DurhamThe WoodlandsManufacturingBiotechnologyManufacturingBiotechnology

Description

Kincell Bio and Cellipont Bioservices have completed their merger to form Kincellis Advanced Therapies. This new entity focuses on developing cell therapies and advanced modalities. The merger combines Kincell's expertise in immune-cell technologies with Cellipont's stem cell experience. Kincellis Advanced Therapies will enhance capabilities in the field of regenerative medicine.

Company Information

Company

Kincell Bio

Location

Durham, North Carolina, United States

About

Kincell Bio is a technology-forward cell therapy cGMP contract development and manufacturing organization (CDMO) situated in the Southeastern United States. The company's mission is to streamline CMC development, with expertise in analytical and process development and GMP manufacturing, testing and release.

Don't miss Kincell Bio's next move

Get an email the moment Kincell Bio makes an acquisition, hires an exec, or expands, usually minutes after it happens.

One email per event. Unsubscribe anytime.

Related People

Bruce
Senior decision-maker at this company
••••••••@••••••••

See Bruce's verified email →

Predictive Intelligence
Strategic

ML-powered predictions for Kincell Bio's next move

Learn about Strategic plan

M&A Insights

Based on deal data
Integration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed

Frequently asked

Who acquired Cellipont Bioservices?

Cellipont Bioservices was acquired by Kincell Bio, based in Durham. The deal was reported on September 17, 2026. Kincell Bio is a technology-forward cell therapy cGMP contract development and manufacturing organization (CDMO) situated in the Southeastern United States. Kincell Bio is privately held and operates in Manufacturing.

When did Kincell Bio acquire Cellipont Bioservices?

Kincell Bio's acquisition of Cellipont Bioservices was reported on September 17, 2026. Kincell Bio and Cellipont Bioservices have completed their merger to form Kincellis Advanced Therapies. This new entity focuses on developing cell therapies and advanced modalities. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Cellipont Bioservices do?

Cellipont Bioservices is a premier Contract Development and Manufacturing Organization (CDMO) specializing in the advancement of cell therapies. It is privately held, operating in Manufacturing, and is based in The Woodlands.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 285,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.